RT Conference Proceedings
T1 Effect of Yellow filter on mesopic contrast threshold with and without glare in myopia corrected by laser in situ keratomileusis (lasik).
T2 Efecto del filtro amarillo sobre el umbral de contraste mesópico con y sin deslumbramiento en la miopía corregida mediante queratomileusis in situ con láser (lasik).
A1 Pérez Carrasco, María Jesús
A1 Puell Marín, María Cinta
A1 Sánchez Ramos, Celia
AB PURPOSE: To determine the effect of a coated yellow filter on contrast threshold with an without glare under mesopic conditions in eyes having uncomplicated excimer laser in situ keratomileusis (LASIK) for myopia.METHODS: The mesopic contrast threshold was measured in the absence or presence of glare using the Mesoptometer II test in 35 right eyes of adult subjects (mean age 36.9 +- 7.4) after 12 and 60 months of LASIK surgery, with and without coated yellow filter ( 482nm cut-off) and 30 emmetropic eyes of adult subjects (mean age 35.2+-4.7) as control group.RESULTS: Lasik group didn`t discrimate the lowest contrast threshold without glare, however a 73.33% of control group reached it. When the yellow filter was interposed in the lasik group the proportion of subjects who discriinated the lowest contrast threshold increased by 20%. With glare, 11.43% of lasik group´s subjects reached the lowest contrast threshold increasing by 14.29% with the yellow filter, and being of 46.67% in the control group. With the yellow filter, the contrast threshold mean improved with glare (p=0.0479) and without glare (p=0.00012) respect the lasik group without filter. Moreover, contrast threshold differences among control and lasik group were statistically significant, obteining the control group the best contrast thresholds with glare (p?0.01) and without glare ( p=0.01)CONCLUSION: The effect of yellow filter without residual reflections had a positive influence on the mesopic ontrast perception of eyes having uncomplicated excimer laser in situ keratomileusis (LASIK) for myopia.
YR 2003
FD 2003-05-09
LK https://hdl.handle.net/20.500.14352/108038
UL https://hdl.handle.net/20.500.14352/108038
LA eng
DS Docta Complutense
RD 10 abr 2025